|
|
||||||||
*These authors contributed equally to this work.
From the Department of Immunology (Drs. Kondo, K. Takahashi, Miyamoto, and Yamamura), National Institute of Neuroscience, NCNP, Tokyo; Department of Neurology (Dr. Kohara), Kobe City General Hospital, Kobe; Department of Neurology (Dr. Y. Takahashi), St. Marianna University of Medicine, Kawasaki; Department of Pathology (Drs. Hayashi and H. Takahashi), Brain Research Institute, Niigata University, Niigata; Department of Neurology (Dr. Matsuo), Kawatana National Hospital, Nagasaki; The Second Department of Internal Medicine (Dr. Yamazaki), Nippon Medical School; and Department of Neurology (Dr. Inoue), Jikei University School of Medicine, Tokyo, Japan.
Address correspondence and reprint requests to Dr. Takashi Yamamura, Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan; e-mail: yamamura{at}ncnp.go.jp
NasuHakola disease (NHD) is an autosomal recessive disorder characterized by presenile dementia and bone cysts. Finnish patients revealed a large deletion in DAP12 gene encoding a key element for transducing activation signal. The authors examined six Japanese cases for DAP12 alleles. Five of the six had loss-of-function mutation, either a single-base deletion or a novel point mutation. The single patient without mutation normally expressed DAP12 protein. Japanese NHD has at least three genetic forms regarding DAP12.
This article has been cited by other articles:
![]() |
S. Gupta, O. Fiertag, and J. Warner Rare and unusual dementias Adv. Psychiatr. Treat., September 1, 2009; 15(5): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fuchs, M. Cella, T. Kondo, and M. Colonna Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44 Blood, September 15, 2005; 106(6): 2076 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Klunemann, B. H. Ridha, L. Magy, J. R. Wherrett, D. M. Hemelsoet, R. W. Keen, J. L. De Bleecker, M. N. Rossor, J. Marienhagen, H. E. Klein, et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2 Neurology, May 10, 2005; 64(9): 1502 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, C. D.P. Rochford, and H. Neumann Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 J. Exp. Med., February 22, 2005; 201(4): 647 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Rosen, M. Araki, J. A. Hamerman, T. Chen, T. Yamamura, and L. L. Lanier A Structural Basis for the Association of DAP12 with Mouse, but Not Human, NKG2D J. Immunol., August 15, 2004; 173(4): 2470 - 2478. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Hancock, M Poon, B Taylor, and C McLean Hereditary diffuse leucoencephalopathy with spheroids J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1345 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cella, C. Buonsanti, C. Strader, T. Kondo, A. Salmaggi, and M. Colonna Impaired Differentiation of Osteoclasts in TREM-2-deficient Individuals J. Exp. Med., August 18, 2003; 198(4): 645 - 651. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |